Replies to post #141652 on Anavex Life Sciences Corp (AVXL)

[McMagyar]

Why would that be unlikely?
It would be unlikely that they did not
Dose ms patients with A2-73 alone and in conjunction with their other drugs..

With the safety factor being so incredible.. why wouldn't they dose MS patients before they risked hundreds of millions of dollars in licensing agreement..

The answer is that they would likely dose patients IF they had access to more a2-73.. Anavex knows how much A2-73 they supply Biogen..

Could Biogen have it made outside the MTA? Probably.. but that would be some criminal stuff. ..doubtful..but not impossible..especially if Anavex refused to provide more A2-73..